Targeted Therapies Improve Outcomes in Renal Cancer and GIST, but Challenges Remain
Targeted therapies have significantly changed the treatment of cancer and are now considered to be a component of care for a number of common malignancies, including breast, colorectal, and lung cancers. In particular, they have significantly improved outcomes for patients with metastatic renal cell carcinoma (mRCC) and advanced gastrointestinal stromal tumors (GIST).
Thromboembolism Prophylaxis Could Reduce Maternal Deaths After C-Section
Although most maternal deaths are not preventable, thromboembolism prophylaxis could reduce death rates in women undergoing cesarean delivery, according to a report in the July American Journal of Obstetrics & Gynecology.
Byetta Linked to Acute Pancreatitis
Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byetta, Amylin Pharmaceuticals, Inc), the US Food and Drug Administration (FDA) advised healthcare professionals today.
New Risk Factors for Cardiovascular Problems After Joint Surgery Identified
In addition to confirming previously identified risk factors for cardiovascular complications after total joint replacement (TJR) surgery, researchers have shown that bilateral and revision operations are associated with increased risk.
More Women Needed, Says American Association of Neurological Surgeons Report
More than half of medical school students are women, and yet they account for only 10% of neurosurgical residents, a new report shows. That number drops to 6% when researchers factor in how many women go on to become practicing neurosurgeons.
Factor VII Curbs Bleeding in Non-Hemophiliac Trauma, Surgical Patients
Use of recombinant activated factor VII (rFVIIa) reduces the need for blood transfusion in patients without hemophilia and may also reduce mortality, according to pooled data from randomized placebo-controlled trials involving more than 3000 participants, Canadian researchers report.
Survival and Functional Outcomes Good After Surgery for Ebstein Anomaly
Most patients who undergo surgery for Ebstein anomaly have good long-term survival and functional outcomes, according to a report in the August 5th issue of the Journal of the American College of Cardiology.
First Heart Transplants in Children Following Donor Cardiac Death
US doctors have reported the first experiences of heart transplant in three infants after cardiocirculatory death, rather than brain death, in the donors [1]. Lead author Dr Mark M Boucek (Joe DiMaggio Children's Hospital, Hollywood, FL) told heartwire this was, to his knowledge, the first published account of heart transplant in children after donor cardiac […]
FDA unexpectedly rejects Schering anesthesia drug
Schering-Plough Corp (nyse: SGP – news – people ) said Friday U.S. regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts and was unanimously recommended by a federal advisory panel.
ASA Achieves Historic Legislative Win of Monumental Proportions!
We helped secure enactment of H.R. 6331—aMedicare bill that includes an immediate positiveMedicare payment update and a permanentfix to the Medicare AnesthesiologyTeaching Rule, beginning in 2010!
